Type of lung cancer-Non-small cell lung carcinoma (NSCLC) Posts on Medivizor
Navigation Menu

Type of lung cancer-Non-small cell lung carcinoma (NSCLC) Posts on Medivizor

Searching for patients with previously treated non-small cell lung cancer to trial an immunotherapy combination

Posted by on Jun 29, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if treating recurrent non-small cell lung cancer with ramucirumab (Cyramza) and pembrolizumab (Keytruda) works better than standard care practices. The main outcome that will be measured is the overall survival rates.  This study will take place in the United States. The details There are a...

Read More

Safety and efficacy of stereotactic body radiotherapy for centrally located non-small cell lung cancer

Posted by on May 31, 2019 in Lung cancer | 0 comments

In a nutshell This article investigated the safety and effectiveness of stereotactic body radiotherapy (SBRT) for centrally located non-small cell lung cancer (NSCLC).  The authors concluded that SBRT is safe and effective for these patients. Some background NSCLC is the most common kind of lung cancer. Patients with...

Read More

Local consolidative therapy – does this improve survival in advanced lung cancer?

Posted by on May 31, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated the effect of local consolidative therapy (LCT) with radiotherapy or surgery in patients with advanced non-small cell lung cancer (NSCLC). They found that LCT prolonged survival in these patients.  Some background Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Metastatic...

Read More

Looking for patients with non-small cell lung cancer to test a new immunotherapy combination

Posted by on May 26, 2019 in Lung cancer | 0 comments

In a nutshell This phase 2 trial will investigate the safety and effectiveness of different treatment combinations containing durvalumab (Imfinzi) in non-small cell lung cancer (NSCLC). The main outcome will be the objective response rate (ORR). The details Non-small cell lung cancer (NSCLC) is a common form of lung cancer. It is often diagnosed at...

Read More

Searching for patients with non-small cell lung cancer suitable for surgery to test durvalumab with chemotherapy

Posted by on May 19, 2019 in Lung cancer | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness of durvalumab (Imfinzi) combined with chemotherapy vs chemotherapy alone for stage II and III non-small cell lung cancer (NSCLC) before surgery. The main outcome to be measured will be the major pathological response (mPR; 10 percent or fewer alive cancer cells...

Read More

Is combined treatment with erlotinib and bevacizumab effective in non-small cell lung cancer?

Posted by on May 18, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness of erlotinib (Tarceva) and bevacizumab (Avastin) compared ti erlotinib alone in non-small cell lung cancer (NSCLC). They found that combined treatment improved survival after 12 months. Some background Non-small cell lung cancer (NSCLC) is a common type of lung cancer (LC)....

Read More

Evaluating crizotinib for patients with non-small cell lung cancer that has spread to the brain

Posted by on May 4, 2019 in Lung cancer | 0 comments

In a nutshell This study evaluated how well crizotinib (Xalkori) works in patients with non-small cell lung cancer (NSCLC) with an ALK mutation that had spread to the brain. This study found that crizotinib treatment improved survival, but not for patients with cancer in the brain that continued to grow. Some background NSCLC is the most common type...

Read More